Management

Mr. Kilcoyne, Micrus' Chief Executive Officer, was elected Chairman in September 2007. Prior Mr. Kilcoyne had served as our President and CEO since December 2004. From April 2002 to April 2004, Mr. Kilcoyne served as the President and Chief Executive Officer of Solace Therapeutics, Inc., a medical device company. From November 1997 to January 2002, he served as the President and Chief Executive Officer of Endonetics, Inc., a medical device company. From February 1997 to November 1997, he served as the Vice President Sales and Marketing and New Business Development at Medical Scientific, Inc., a medical device company. From July 1993 to February 1997, he served as the Director of Marketing at Microsurge, Inc., a medical device company. Mr. Kilcoyne served in various sales and marketing positions with Guidant and Boston Scientific. Mr. Kilcoyne received his B.S. from Cornell University. Mr. Kilcoyne serves as a member of the board of directors of Onset Medical, a private company.

Mr. Stern was promoted to President and Chief Operating Officer in September 2007. Prior Mr. Stern had served as our Executive Vice President and Chief Financial Officer since November 2004, and Vice President, Finance and Administration and Chief Financial Officer since January 2004 and was appointed our Secretary in March 2005. From September 2000 to January 2004, Mr. Stern served as the President and Chief Executive Officer of Context Connect, Inc., a telecommunications company. From March 2000 to September 2000, he served as the Executive Vice President of Quixel Capital Group, an investment holding company. From January 1996 to March 2000, he served as the Vice President and Chief Financial Officer of InnerDyne, Inc., a medical device company. From October 1991 to January 1996, he served as Vice President, Corporate Finance and Chief Financial Officer of RhoMed Incorporated, a pharmaceutical company. Mr. Stern received his B.S. in Business Administration from the University of New Hampshire, Whittemore School of Business and Economics, and his MBA from the University of New Mexico, Anderson School of Management. Mr. Stern serves as a member of the board of directors of UltraTouch Corporation, a private company, and Context Connect, Inc., a private company.

Mr. Sangster joined Micrus in November 2007 as our Chief Financial Officer. He most recently served as Vice President of Finance and Chief Financial Officer of HemoSense, Inc., a publicly traded point-of-care clinical diagnostics company. From August 2000 through October 2006, Mr. Sangster was Chief Financial Officer of A.P. Pharma, Inc., a publicly traded specialty pharmaceutical company. From April 1993 to July 2000, he served as A.P. Pharma's vice president of finance and controller. He is a member of the Institute of Chartered Accountants in England and Wales.

Ms. Bruguera joined Micrus in November 2005 as our Vice President and General Counsel. From March 2004 to November 2005, she was a partner with Montgomery Law Group in Menlo Park, specializing in corporate and securities law, and from 2000 to 2004 she was a partner with Thoits, Love, Hershberger & McLean in Palo Alto, which she joined as an associate in 1998. She was an associate with Venture Law Group from 1995-1998 and with Heller, Ehrman, White & McAuliffe from 1993-1995.

Ms. Bruguera received her J.D. from the University of California, Berkeley's Boalt Hall School of Law, and her A.B. from Harvard University.

Mr. Colloton joined us in March 2005 and is our Vice President, US Sales and Global Marketing. From February 2003 to March 2005, Mr. Colloton served as the Vice President, Account and Market Development of VNUS Medical Technologies, Inc., a medical device company. Prior to this position, he also held the positions of Vice President, Worldwide Marketing and International Sales from April 2001 to February 2003 and Vice President, Worldwide Sales and Marketing from June 1999 to April 2001, at VNUS Medical Technologies, Inc. From June 1997 to June 1999, Mr. Colloton served as Vice President, Sales and Marketing of TransVascular, Inc., a medical device company. From January 1993 to June 1997, he served in various sales and marketing executive positions at Cardiometrics, Inc. Mr. Colloton received his B.S. in Business Administration at Miami University in Oxford, Ohio.

Mr. Crompton joined Micrus in October 2006 as our Vice President, Regulatory/Clinical Affairs & Quality. From June 2005 to October 2006 he was a consultant to medical device companies, including the position as Vice President, Regulatory/Clinical Affairs and Quality Assurance at Spinal Kinetics, Inc., a medical device company. From October 2002 to June 2005, he served as the Vice President, Regulatory/Clinical Affairs/Quality Assurance & Chief Compliance Officer for Carl Zeiss Meditec, Inc., a medical device company. From December 2000 to September 2002 he was the Vice President, Regulatory/Clinical Affairs and Quality Assurance at CryoVascular Systems, Inc., a medical device company. From May 1996 to November 2000 he was the Vice President, Regulatory Affairs & Quality Assurance at Symphonix Devices, Inc., a medical device company. Mr. Crompton received his bachelors degree in biochemistry and a M.P.H. in biomedical sciences from the University of California at Berkeley. He received his J.D. from the University of San Francisco School of Law.

Mr. Ruppel joined us in June 2003 and is our Vice President, Technical Operations. From March 2001 to March 2003, Mr. Ruppel served as the Vice President of Operations of CBYON, Inc., a surgical navigation software and equipment company. From June 1994 to December 2000, he served as Director of Operations, among other management positions, for Biometric Imaging, a subsidiary of Becton, Dickinson & Company, a medical technology company. Mr. Ruppel received his B.S. in Mechanical Engineering at the University of Rochester.